Position in VCYT
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$7,341,250
+$3,315,000 QoQ
Shares Held
125,000
0.0% QoQ
Ownership
0.157%
of shares outstanding
% of Portfolio
0.82%
of 13F equity value
Holder Rank
#4
of 67 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VCYT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026ARDSLEY ADVISORY PARTNERS LP holds $12,490,000 across 2 Diagnostics & Research names. VCYT ranks #1 (58.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VCYT |
Veracyte, Inc.
This page
|
125,000 | $7,341,250 | |
| 2 | WGS |
GeneDx Holdings Corp.
|
75,000 | $5,148,750 |
All Filings in VCYT
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,341,250 | 125,000 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $4,026,250 | 125,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,262,500 | 125,000 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||